Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene Transfer is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01AR064369-02
Overcoming our clinical complications: AAV vector design for the treatment of DMD
National Institutes of Health
Grant: 5P30CA016086-33
CORE--PROTEOMICS
National Institutes of Health
Grant: 1R01AI072176-01A1
Rational and combinatorial engineering of AAV vectors
National Institutes of Health
Grant: 5U54AR056953-05
National Vector Muscular Dystrophy Core
National Institutes of Health
Grant: 5R01DK084033-06
AAV Gene Therapy for AAT Deficiency
National Institutes of Health
Grant: 5P01HL112761-03
ANIMAL MODELS CORE
National Institutes of Health
Grant: 2R01GM082946-06A1
AAV capsids and their cellular interactions
Fields of Study
Keywords
Sustainable Development Goals